DNA methylation-based classifier and gene expression signatures detect BRCAness in osteosarcoma.
Although osteosarcoma (OS) is a rare cancer, it is the most common primary malignant bone tumor in children and adolescents. BRCAness is a phenotypical trait in tumors with a defect in homologous recombination repair, resembling tumors with inactivation of BRCA1/2, rendering these tumors sensitive t...
Guardado en:
Autores principales: | Maxim Barenboim, Michal Kovac, Baptiste Ameline, David T W Jones, Olaf Witt, Stefan Bielack, Stefan Burdach, Daniel Baumhoer, Michaela Nathrath |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/48d2d56a1dde466598a0484db6c4ce39 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
DNA methylation-based classifier and gene expression signatures detect BRCAness in osteosarcoma
por: Maxim Barenboim, et al.
Publicado: (2021) -
BRCAness profile of sporadic ovarian cancer predicts disease recurrence.
por: Weiya Z Wysham, et al.
Publicado: (2012) -
Current Insights into the Management of Late Chemotherapy Toxicities in Pediatric Osteosarcoma Patients
por: Hecker-Nolting S, et al.
Publicado: (2021) -
Development and Validation of Ten-RNA Binding Protein Signature Predicts Overall Survival in Osteosarcoma
por: Jian Zhang, et al.
Publicado: (2021) -
A Novel Pyroptosis-Related Signature for Predicting Prognosis and Indicating Immune Microenvironment Features in Osteosarcoma
por: Yiming Zhang, et al.
Publicado: (2021)